NVIV(Delisted)
Invivo Therapeutics·NASDAQ
--
--(--)
NVIV fundamentals
Invivo Therapeutics (NVIV) released its earnings on Mar 12, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 12, 2018
EPS
Revenue
Revenue & Expenses
Key Indicators
Invivo Therapeutics (NVIV) key financial stats and ratios, covering profitability, financial health, and leverage.
Invivo Therapeutics (NVIV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Invivo Therapeutics (NVIV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Invivo Therapeutics (NVIV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Invivo Therapeutics (NVIV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Invivo Therapeutics (NVIV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
